These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38275388)

  • 1. Induction of Collagenolytic MMP-8 and -9 Tissue Destruction Cascade in Mouth by Head and Neck Cancer Radiotherapy: A Cohort Study.
    Brandt E; Keskin M; Räisänen IT; Tervahartiala T; Mäkitie A; Harmankaya İ; Karaçetin D; Hagström J; Rautava J; Sorsa T
    Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38275388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: a pilot study.
    Keskin M; Lähteenmäki H; Rathnayake N; Räisänen IT; Tervahartiala T; Pärnänen P; Şenışık AM; Karaçetin D; Yentek Balkanay A; Heikkilä P; Hagström J; Rautava J; Haglund C; Gursoy UK; Silbereisen A; Bostanci N; Sorsa T
    Expert Rev Proteomics; 2020 Oct; 17(10):777-784. PubMed ID: 33406924
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiotherapy Increases aMMP-8-Levels and Neutrophil/Lymphocyte Ratio Rapidly in Head and Neck Cancer Patients: A Pilot Study.
    Brandt E; Keskin M; Tervahartiala T; Yılmaz M; Harmankaya İ; Karaçetin D; İpek T; Gürsoy UK; Rautava J; Gupta S; Hagström J; Räisänen IT; Sorsa T
    Cancer Control; 2023; 30():10732748231163653. PubMed ID: 37092545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
    Sorsa T; Sahni V; Buduneli N; Gupta S; Räisänen IT; Golub LM; Lee HM; Pätilä T; Bostanci N; Meurman J; Pärnänen P; Nwhator SO; Singla M; Gauba K
    Expert Rev Proteomics; 2021 Aug; 18(8):707-717. PubMed ID: 34468272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active MMP-8 point-of-care (PoC)/chairside enzyme-test as an adjunctive tool for early and real-time diagnosis of peri-implantitis.
    Lähteenmäki H; Tervahartiala T; Räisänen IT; Pärnänen P; Mauramo M; Gupta S; Sampson V; Rathnayake N; Heikkinen AM; Alassiri S; Gieselmann DR; Frankenberger R; Sorsa T
    Clin Exp Dent Res; 2022 Apr; 8(2):485-496. PubMed ID: 35118828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between different protein species of oral rinse MMP-8 and patient-related factors.
    Leppilahti JM; Tervahartiala T; Kautiainen H; Räisänen I; Ahonen MM; Uitto VJ; Sorsa T; Mäntylä P
    Clin Exp Dent Res; 2023 Dec; 9(6):1021-1033. PubMed ID: 37877535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases.
    Sorsa T; Nwhator SO; Sakellari D; Grigoriadis A; Umeizudike KA; Brandt E; Keskin M; Tervahartiala T; Pärnänen P; Gupta S; Mohindra R; Bostanci N; Buduneli N; Räisänen IT
    Front Oral Health; 2022; 3():897115. PubMed ID: 35757444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics.
    Räisänen IT; Aji NRAS; Sakellari D; Grigoriadis A; Rantala I; Pätilä T; Heikkilä P; Gupta S; Sorsa T
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active MMP-8 (aMMP-8) as a Grading and Staging Biomarker in the Periodontitis Classification.
    Sorsa T; Alassiri S; Grigoriadis A; Räisänen IT; Pärnänen P; Nwhator SO; Gieselmann DR; Sakellari D
    Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31979091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of gingival crevicular fluid matrix metalloproteinase-8 provides site-specific diagnostic value for periodontal grading.
    Nędzi-Góra M; Górska R; Górski B
    Cent Eur J Immunol; 2021; 46(2):236-243. PubMed ID: 34764793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of active matrix metalloproteinase-8 point-of-care test for the discrimination of periodontal health status: Comparison of saliva and oral rinse samples.
    Deng K; Wei S; Xu M; Shi J; Lai H; Tonetti MS
    J Periodontal Res; 2022 Aug; 57(4):768-779. PubMed ID: 35575900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study.
    Hernández M; Gamonal J; Tervahartiala T; Mäntylä P; Rivera O; Dezerega A; Dutzan N; Sorsa T
    J Periodontol; 2010 Nov; 81(11):1644-52. PubMed ID: 20653434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-8 levels in oral samples as a biomarker for periodontitis in the Chinese population: an observational study.
    Yuan C; Liu X; Zheng S
    BMC Oral Health; 2018 Mar; 18(1):51. PubMed ID: 29587716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease.
    Emingil G; Tervahartiala T; Mãntylã P; Määttä M; Sorsa T; Atilla G
    J Periodontol; 2006 Dec; 77(12):2040-50. PubMed ID: 17209789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis.
    Leppilahti JM; Hernández-Ríos PA; Gamonal JA; Tervahartiala T; Brignardello-Petersen R; Mantyla P; Sorsa T; Hernández M
    J Clin Periodontol; 2014 Apr; 41(4):348-56. PubMed ID: 24382144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease).
    Rathnayake N; Gustafsson A; Norhammar A; Kjellström B; Klinge B; Rydén L; Tervahartiala T; Sorsa T;
    PLoS One; 2015; 10(7):e0126370. PubMed ID: 26132583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.
    Gupta S; Mohindra R; Singla M; Khera S; Kumar A; Rathnayake N; Sorsa T; Pfützner A; Räisänen IT; Soni RK; Kanta P; Jain A; Gauba K; Goyal K; Singh MP; Ghosh A; Kajal K; Mahajan V; Suri V; Bhalla A
    Clin Exp Dent Res; 2022 Aug; 8(4):988-1001. PubMed ID: 35818743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.
    Tüter G; Kurtiş B; Serdar M
    J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis.
    Alpagot T; Bell C; Lundergan W; Chambers DW; Rudin R
    J Clin Periodontol; 2001 Apr; 28(4):353-9. PubMed ID: 11314892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory biomarkers in saliva and serum of patients with rheumatoid arthritis with respect to periodontal status.
    Äyräväinen L; Heikkinen AM; Kuuliala A; Ahola K; Koivuniemi R; Laasonen L; Moilanen E; Hämäläinen M; Tervahartiala T; Meurman JH; Leirisalo-Repo M; Sorsa T
    Ann Med; 2018 Jun; 50(4):333-344. PubMed ID: 29683364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.